AbbVie

www.abbvie.com

Department R4LA-AP-32LL
1 North Waukegan Road
North Chicago
IL 60064
United States

Activities

Pharmaceutical

Related Content

Therapeutic: atogepant for migraine
Therapeutic: atogepant for migraine
AbbVie strengthen’s neuroscience portfolio with acquisition
AbbVie strengthen’s neuroscience portfolio with acquisition
AbbVie and Eisai launch online Humira support tool service
AbbVie and Eisai launch online Humira support tool service
CMC strategies for the acceleration of commercial-ready ADC manufacturing
CMC strategies for the acceleration of commercial-ready ADC manufacturing
GlobalData publishes analysis of top 25 global pharma companies
GlobalData publishes analysis of top 25 global pharma companies
Risankizumab approval could strengthen AbbVie's market position
Risankizumab approval could strengthen AbbVie's market position
AbbVie and Eisai obtain additional approval for Humira
AbbVie and Eisai obtain additional approval for Humira
GlobalData names top 25 global pharma companies by market cap
GlobalData names top 25 global pharma companies by market cap
Inventiva and AbbVie extend agreement for drug discovery
Inventiva and AbbVie extend agreement for drug discovery
Groundbreaking declaratory relief clears the route to market for Humira biosimilars
Groundbreaking declaratory relief clears the route to market for Humira biosimilars
Vetter is a winner of the AbbVie Triumph Award
Vetter is a winner of the AbbVie Triumph Award
AbbVie and University of Chicago collaborate to advance cancer research
AbbVie and University of Chicago collaborate to advance cancer research
F-star inks agreement with AbbVie
F-star inks agreement with AbbVie
Rheumatoid arthritis – sarilumab
Rheumatoid arthritis – sarilumab
High hopes for cannabis
High hopes for cannabis